Medicina
Departamento
Poznan University of Medical Sciences
Posnania, PoloniaPublicaciones en colaboración con investigadores/as de Poznan University of Medical Sciences (8)
2024
-
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 4, pp. 1576-1593
2023
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
2019
-
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248
-
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656
2018
-
Deklaracja medycznego środowiska kardiologicznego, paliatywnego i internistycznego wskazująca na znaczenie opieki paliatywnej w kompleksowej opiece nad chorymi z niewydolnością serca
Palliative Medicine in Practice
-
Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Current Medical Research and Opinion, Vol. 34, Núm. 5, pp. 865-871
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380